Human medicines European public assessment report (EPAR): Ryzodeg, insulin degludec / insulin aspart, Diabetes Mellitus, Date of authorisation: 21/01/2013, Revision: 11, Status: Authorised

2019 ◽  
Author(s):  
Keyword(s):  
Diabetes Mellitus ◽  
Insulin Aspart ◽  
Insulin Degludec ◽  
Assessment Report ◽  
European Public ◽  
European Public Assessment Report
Sign in / Sign up

Export Citation Format

Share Document